JELD vs ULBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JELD is in a state of severe financial distress, evidenced by a critical Piotroski F-Score of 1/9 and a catastrophic Debt/Equity ratio of 14.81. The company is experiencing a death spiral characterized by negative profit margins (-19.34%), collapsing ROE (-174.72%), and consistent earnings misses (0/4 in the last year). While the Price/Sales ratio is nominally low at 0.04, this is a value trap given the negative growth and extreme leverage. The recent short-term price bounce is likely speculative and not supported by fundamental recovery.
ULBI presents a contradictory profile: a stable Piotroski F-Score of 6/9 and strong liquidity are offset by deteriorating profitability and severe earnings misses. While the stock trades attractively on a Price-to-Book (0.99) and Price-to-Sales (0.68) basis, the negative profit margins and a high PEG ratio (3.81) suggest that the recent price surge is disconnected from fundamental earnings growth. The company's stability is anchored by a low Debt/Equity ratio (0.41), but high customer concentration and consistent EPS underperformance create significant risk.
Compare Another Pair
Related Comparisons
JELD vs ULBI: Head-to-Head Comparison
This page compares JELD-WEN Holding, Inc. (JELD) and Ultralife Corporation (ULBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.